15 results on '"Kreijne, Joany E."'
Search Results
2. No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis
3. Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease
4. Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohnʼs Disease
5. Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment
6. Sa1772 – Prevalence of Cervical Dysplasia in Women with Inflammatory Bowel Disease: Data from the Parelsnoer Institute (PSI) and Palga Database (PAP-IBD Study)
7. Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients.
8. 818 - Tacrolimus Suppositories as Induction Therapy for Refractory Ulcerative Proctitis: A Randomized Controlled Trial
9. Sa1691 - Monitoring of Laboratory Parameters During Thiopurine Maintenance Therapy in Patietns with Inflammatory Bowel Disease: An Unnecessary Burden?
10. Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease
11. 6‐methylmercaptopurine‐induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients
12. An unexpected cause of terminal ileitis
13. Mo1894 Gender Differences in Adalimumab Continuation Rates, Results of a Prospective Crohn's Disease Cohort
14. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease
15. Real-life study of safety of thiopurine-allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.